This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Healthcare Providers Increase Revenues, Avoid Penalties Through Covisint PQRS Program, A Stepping-Stone For ACO Success

DETROIT, Feb. 18, 2013 (GLOBE NEWSWIRE) -- Covisint, a Compuware (Nasdaq:CPWR) company, announced today that it has surpassed the $30 million mark in money returned to healthcare customers through the company's easy-to-use, PQRS solution. This achievement extends Covisint's position as one of the nation's PQRS submission leaders.
Compuware Logo
Covisint Logo

The March 8, 2013, PQRS submissions deadline is fast-approaching for the final opportunity to earn reimbursements in the last penalty-free year of this program. Covisint provides multiple reporting options, including a larger enterprise data-mining solution and, for individual providers or smaller practices, a web application that can take as little as 30 minutes to satisfy PQRS submission requirements.

As ACO and other shared savings programs expand, Covisint's PQRS submission program offers a speedy path to gain experience in ACO reporting due to the overlap in chronic disease and preventive care measures. Covisint has a 90 percent-plus PQRS customer retention rate.

Covisint lets providers use data captured during patient encounters, traditionally enabling them to earn an average of $1,000; practices can earn up to as much as $18,500 depending on their Medicare Part B Fee-for-Service allowed annual charges. This year, Covisint encourages providers to report for three key reasons:

1. to earn the 0.5 percent bonuses available from Centers for Medicare and Medicaid for 2012;

2. to gain the experience needed to successfully report in 2013--avoiding payment penalties of 1.5 percent on their 2015 fee schedule; and,

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs